Chetty, RunjanGill, PBateman, AdrianDriman, David KGovender, DhirendraBateman, Andrew RChua, Yu JoGreywoode, GodmanHemmings, ChristineImat, IJaynes, EleanorSoon Lee, Cheok2015-12-100021-9746http://hdl.handle.net/1885/39282Keywords: capecitabine; fluorouracil; advanced cancer; cancer chemotherapy; cancer grading; cancer prognosis; cancer radiotherapy; cancer regression; editorial; fibrosis; histopathology; human; pathology; priority journal; rectum cancer; Chemoradiotherapy; Humans;Pathological grading of regression: an International Study Group perspective201210.1136/jclinpath-2012-2010542016-02-24